Home > > North America And Global Point of Care Molecular Diagnostics Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET 3.1. OVERVIEW 3.2. NORTH AMERICA 3.2.1. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.2. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.3. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY 3.2.4.1. U.S. 3.2.4.1.1. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.1.2. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.1.3. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.2. CANADA 3.2.4.2.1. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.2.2. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.2.3. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.3. MEXICO 3.2.4.3.1. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.3.2. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.3.3. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.3. EUROPE CHAPTER 4: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 4.1. OVERVIEW 4.2. INFECTIOUS DISEASE 4.2.1. INFECTIOUS DISEASE MARKET, BY REGION 4.2.1.1. NORTH AMERICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.2. EUROPE INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.3. ASIA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.3. ONCOLOGY 4.3.1. ONCOLOGY MARKET, BY REGION 4.3.1.1. NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY 4.3.1.2. EUROPE ONCOLOGY MARKET, BY COUNTRY 4.3.1.3. ASIA ONCOLOGY MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA ONCOLOGY MARKET, BY COUNTRY 4.4. HEMATOLOGY 4.4.1. HEMATOLOGY MARKET, BY REGION 4.4.1.1. NORTH AMERICA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.2. EUROPE HEMATOLOGY MARKET, BY COUNTRY 4.4.1.3. ASIA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HEMATOLOGY MARKET, BY COUNTRY 4.5. OTHER APPLICATIONS 4.5.1. OTHER APPLICATIONS MARKET, BY REGION 4.5.1.1. NORTH AMERICA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.2. EUROPE OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.3. ASIA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET, BY COUNTRY CHAPTER 5: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 5.1. OVERVIEW 5.2. HOSPITALS 5.2.1. HOSPITALS MARKET, BY REGION 5.2.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 5.2.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 5.2.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 5.3. CLINICS 5.3.1. CLINICS MARKET, BY REGION 5.3.1.1. NORTH AMERICA CLINICS MARKET, BY COUNTRY 5.3.1.2. EUROPE CLINICS MARKET, BY COUNTRY 5.3.1.3. ASIA CLINICS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA CLINICS MARKET, BY COUNTRY 5.4. OTHER END USERS 5.4.1. OTHER END USERS MARKET, BY REGION 5.4.1.1. NORTH AMERICA OTHER END USERS MARKET, BY COUNTRY 5.4.1.2. EUROPE OTHER END USERS MARKET, BY COUNTRY 5.4.1.3. ASIA OTHER END USERS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA OTHER END USERS MARKET, BY COUNTRY CHAPTER 6: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 6.1. OVERVIEW 6.2. PCR 6.2.1. PCR MARKET, BY REGION 6.2.1.1. NORTH AMERICA PCR MARKET, BY COUNTRY 6.2.1.2. EUROPE PCR MARKET, BY COUNTRY 6.2.1.3. ASIA PCR MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PCR MARKET, BY COUNTRY 6.3. IN SITU HYBRIDIZATION 6.3.1. IN SITU HYBRIDIZATION MARKET, BY REGION 6.3.1.1. NORTH AMERICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.2. EUROPE IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.3. ASIA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.4. SEQUENCING 6.4.1. SEQUENCING MARKET, BY REGION 6.4.1.1. NORTH AMERICA SEQUENCING MARKET, BY COUNTRY 6.4.1.2. EUROPE SEQUENCING MARKET, BY COUNTRY 6.4.1.3. ASIA SEQUENCING MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA SEQUENCING MARKET, BY COUNTRY 6.5. ISOTHERMAL AMPLIFICATION 6.5.1. ISOTHERMAL AMPLIFICATION MARKET, BY REGION 6.5.1.1. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.2. EUROPE ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.3. ASIA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.4. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.6. OTHER TECHNOLOGIES 6.6.1. OTHER TECHNOLOGIES MARKET, BY REGION 6.6.1.1. NORTH AMERICA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.2. EUROPE OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.3. ASIA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.4. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET, BY COUNTRY TABLE 81. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 02. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 03. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 04. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($MILLION) TABLE 07. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 08. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) TABLE 09. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 11. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 12. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 13. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 14. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 15. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 16. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 17. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 18. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 19. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 20. INFECTIOUS DISEASE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 21. NORTH AMERICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. EUROPE INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 23. ASIA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ONCOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 26. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 28. ASIA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. MIDDLE EAST & AFRICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. HEMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 31. NORTH AMERICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. EUROPE HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. ASIA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. MIDDLE EAST & AFRICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 36. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. ASIA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 41. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 42. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. CLINICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 47. NORTH AMERICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. EUROPE CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. ASIA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. MIDDLE EAST & AFRICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. OTHER END USERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 52. NORTH AMERICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. EUROPE OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. ASIA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 57. PCR MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 58. NORTH AMERICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. EUROPE PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. ASIA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. MIDDLE EAST & AFRICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. IN SITU HYBRIDIZATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 63. NORTH AMERICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. EUROPE IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. ASIA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. SEQUENCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 68. NORTH AMERICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. EUROPE SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. ASIA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. MIDDLE EAST & AFRICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. ISOTHERMAL AMPLIFICATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 73. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. EUROPE ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. ASIA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 77. OTHER TECHNOLOGIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 78. NORTH AMERICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. EUROPE OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. ASIA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET 3.1. OVERVIEW 3.2. NORTH AMERICA 3.2.1. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.2. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.3. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY 3.2.4.1. U.S. 3.2.4.1.1. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.1.2. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.1.3. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.2. CANADA 3.2.4.2.1. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.2.2. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.2.3. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.3. MEXICO 3.2.4.3.1. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.3.2. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.3.3. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.3. EUROPE CHAPTER 4: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 4.1. OVERVIEW 4.2. INFECTIOUS DISEASE 4.2.1. INFECTIOUS DISEASE MARKET, BY REGION 4.2.1.1. NORTH AMERICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.2. EUROPE INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.3. ASIA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.3. ONCOLOGY 4.3.1. ONCOLOGY MARKET, BY REGION 4.3.1.1. NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY 4.3.1.2. EUROPE ONCOLOGY MARKET, BY COUNTRY 4.3.1.3. ASIA ONCOLOGY MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA ONCOLOGY MARKET, BY COUNTRY 4.4. HEMATOLOGY 4.4.1. HEMATOLOGY MARKET, BY REGION 4.4.1.1. NORTH AMERICA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.2. EUROPE HEMATOLOGY MARKET, BY COUNTRY 4.4.1.3. ASIA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HEMATOLOGY MARKET, BY COUNTRY 4.5. OTHER APPLICATIONS 4.5.1. OTHER APPLICATIONS MARKET, BY REGION 4.5.1.1. NORTH AMERICA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.2. EUROPE OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.3. ASIA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET, BY COUNTRY CHAPTER 5: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 5.1. OVERVIEW 5.2. HOSPITALS 5.2.1. HOSPITALS MARKET, BY REGION 5.2.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 5.2.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 5.2.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 5.3. CLINICS 5.3.1. CLINICS MARKET, BY REGION 5.3.1.1. NORTH AMERICA CLINICS MARKET, BY COUNTRY 5.3.1.2. EUROPE CLINICS MARKET, BY COUNTRY 5.3.1.3. ASIA CLINICS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA CLINICS MARKET, BY COUNTRY 5.4. OTHER END USERS 5.4.1. OTHER END USERS MARKET, BY REGION 5.4.1.1. NORTH AMERICA OTHER END USERS MARKET, BY COUNTRY 5.4.1.2. EUROPE OTHER END USERS MARKET, BY COUNTRY 5.4.1.3. ASIA OTHER END USERS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA OTHER END USERS MARKET, BY COUNTRY CHAPTER 6: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 6.1. OVERVIEW 6.2. PCR 6.2.1. PCR MARKET, BY REGION 6.2.1.1. NORTH AMERICA PCR MARKET, BY COUNTRY 6.2.1.2. EUROPE PCR MARKET, BY COUNTRY 6.2.1.3. ASIA PCR MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PCR MARKET, BY COUNTRY 6.3. IN SITU HYBRIDIZATION 6.3.1. IN SITU HYBRIDIZATION MARKET, BY REGION 6.3.1.1. NORTH AMERICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.2. EUROPE IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.3. ASIA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.4. SEQUENCING 6.4.1. SEQUENCING MARKET, BY REGION 6.4.1.1. NORTH AMERICA SEQUENCING MARKET, BY COUNTRY 6.4.1.2. EUROPE SEQUENCING MARKET, BY COUNTRY 6.4.1.3. ASIA SEQUENCING MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA SEQUENCING MARKET, BY COUNTRY 6.5. ISOTHERMAL AMPLIFICATION 6.5.1. ISOTHERMAL AMPLIFICATION MARKET, BY REGION 6.5.1.1. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.2. EUROPE ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.3. ASIA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.4. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.6. OTHER TECHNOLOGIES 6.6.1. OTHER TECHNOLOGIES MARKET, BY REGION 6.6.1.1. NORTH AMERICA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.2. EUROPE OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.3. ASIA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.4. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET, BY COUNTRY TABLE 01. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 02. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 03. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 04. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($MILLION) TABLE 07. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 08. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) TABLE 09. NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 11. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 12. U.S. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 13. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 14. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 15. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 16. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 17. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 18. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 19. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 20. INFECTIOUS DISEASE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 21. NORTH AMERICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. EUROPE INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 23. ASIA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ONCOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 26. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 28. ASIA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. MIDDLE EAST & AFRICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. HEMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 31. NORTH AMERICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. EUROPE HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. ASIA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. MIDDLE EAST & AFRICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 36. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. ASIA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 41. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 42. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. CLINICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 47. NORTH AMERICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. EUROPE CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. ASIA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. MIDDLE EAST & AFRICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. OTHER END USERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 52. NORTH AMERICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. EUROPE OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. ASIA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 57. PCR MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 58. NORTH AMERICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. EUROPE PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. ASIA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. MIDDLE EAST & AFRICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. IN SITU HYBRIDIZATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 63. NORTH AMERICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. EUROPE IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. ASIA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. SEQUENCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 68. NORTH AMERICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. EUROPE SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. ASIA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. MIDDLE EAST & AFRICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. ISOTHERMAL AMPLIFICATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 73. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. EUROPE ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. ASIA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 77. OTHER TECHNOLOGIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 78. NORTH AMERICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. EUROPE OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. ASIA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)